Q3 2025 Earnings Call October 29, 2025 4:30 PM EDTCompany ParticipantsChristopher Lewis - Vice President of Investor ...
Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely ...
In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.
EINPresswire/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors Next-Generation Sequencing (NGS) In Precision ...
Natural Gas Services (NGS) is a top small-cap growth pick in the booming natural gas sector. Read here for an investment analysis.
Overview of Epigenetics MarketThe global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a value of USD 9.11 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...
AI ‘eats’ data. We all know the garbage-in-garbage-out analogy and we understand why AI intelligence itself is inherently ...
Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...
Tensions at Manhattan's immigration courts are reaching a boiling point. Last week, Immigration and Customs Enforcement reinstated the officer who was initially relieved of duties after shoving an ...
At this time, I would like to welcome you to the Glaukos Corporation's Third Quarter 2025 Financial Results Conference Call. Joining me is Glaukos Corporation's Chairman and CEO, Thomas William Burns, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results